Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Wai Chun Bio-Technology Ltd. ( (HK:0660) ) is now available.
Wai Chun Bio-Technology Ltd. announced the results of its Extraordinary General Meeting (EGM) held on September 17, 2025, where a resolution regarding the issuance of new convertible bonds was unanimously approved. This decision is contingent upon several conditions, including approval from the Hong Kong Stock Exchange and the Grand Court of the Cayman Islands. The approval of this resolution is expected to impact the company’s financial strategy and shareholder value positively.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. The company is listed on the Hong Kong Stock Exchange and focuses on the development and commercialization of bio-technological products and services.
Average Trading Volume: 357,758
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.95M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.